炎症和免疫生物标志物:了解和管理糖尿病并发症的新前沿
Polu Picheswara Rao1, Shubham Mishra2, Jaya Gupta3
1Department of Intellectual Property Rights, Research and Development Cell, Lovely Professional University, Jalandhar - Delhi Grand Trunk Road, Phagwara, Punjab, 144411, India. kapil01pharm@gmail.com.
慢性炎症导致糖尿病并发症. 像NLR和PLR这样的新型炎症生物标志物提供了可访问的风险预测,指导了超出血糖控制的新型抗炎疗法.
科学领域:
- 内分泌学和免疫学.
- 生物标志物发现发现
- 糖尿病并发症 研究 研究 糖尿病并发症
背景情况:
- 慢性炎症和免疫失调是糖尿病并发症的关键驱动因素,影响血管系统,脏,视网膜和神经.
- 促炎性细胞因子 (TNF-α,IL-6,IL-1β) 激活炎症级联,导致组织损伤.
- 现有的范式正在转向理解炎症在糖尿病发病过程中的核心作用.
研究的目的:
- 审查糖尿病中免疫媒介损伤的分子机制.
- 评估新出现的炎症生物标志物的预后和诊断价值.
- 讨论在糖尿病管理中针对炎症的治疗进展.
主要方法:
- 对有关炎症和糖尿病并发症的现有文献进行批判性评估.
- 血液学炎症生物标志物 (NLR,PLR,SII,SIRI) 的评估.
- 讨论将生物标志物与精准医学的omics数据集成.
主要成果:
- 血液学炎症标志物 (NLR,PLR,SII,SIRI) 是微和宏血管并发症的成本有效预测剂.
- 这些标记物与胰岛素耐药性,β细胞功能障碍和氧化应激相关.
- 新型抗炎和免疫调节疗法显示出有前途.
结论:
- 针对炎症的策略对于糖尿病管理至关重要,它补充了血糖控制.
- 生物标志物验证和临床翻译仍然是一个挑战.
- 针对炎症提供了减少糖尿病并发症的全球负担的潜力.
更多相关视频
12:33A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
